rxstat › Shortages › Recombinant Human Papillomavirus Type 6 L1 Protein 11 16 18

Recombinant Human Papillomavirus Type 6 L1 Protein 11 16 18 (Gardasil) shortage status

Discontinued

Source: Health Canada shortage reports · Updated Jul 9, 2026

Recombinant Human Papillomavirus Type 6 L1 Protein 11 16 18 products have been discontinued in Canada. See the reports below for which products and when.

A vaccine used to protect against human papillomavirus (HPV) infection and related cancers.

Products affected
0 / 1
Reports on file
2

Reports by product

The DIN is printed on your prescription label.

Discontinued
GARDASIL
20MCG 40MCG 40MCG 20MCG · SUSPENSION · MERCK CANADA INC
DIN 02283190
Discontinued
GARDASIL
20MCG 40MCG 40MCG 20MCG · SUSPENSION · MERCK CANADA INC
DIN 02283190

What's happening

One or more Recombinant Human Papillomavirus Type 6 L1 Protein 11 16 18 products have been permanently discontinued by their manufacturers. If your product is affected, ask your pharmacist about equivalent products still on the market.

Recombinant Human Papillomavirus Type 6 L1 Protein 11 16 18 is classified under “VIRAL VACCINES” (ATC J07BM).

Recent changes

Common questions

What is Recombinant Human Papillomavirus Type 6 L1 Protein 11 16 18 used for?

A vaccine used to protect against human papillomavirus (HPV) infection and related cancers.

When will Recombinant Human Papillomavirus Type 6 L1 Protein 11 16 18 be back in stock in Canada?

Manufacturers have not provided a reliable end date. This page updates automatically as soon as an estimate is filed.

Why is Recombinant Human Papillomavirus Type 6 L1 Protein 11 16 18 in shortage?

See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.

What can my pharmacist do about it?

Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.

Email alerts

Get an email when this drug's status changes. Double opt-in, one-click unsubscribe.

Related drugs (viral vaccines)

Twinrix Junior (Hepatitis B Surface Antigen A Virus / Inactivated) Partial shortage 1 of 2 reported products affected Priorix-Tetra (Mumps Virus Live Attenuated Measles Varicella-zoster Rubella) Shortage anticipated 0 of 1 reported products affected *sarscov2 S-protein Mrna / 5'[m27 / 3'-ogppp (Comirnaty) No current shortage Chikungunya Virus Live-attenuated (Ixchiq) No current shortage Haemagglutinin-strain A B (Flulaval Tetra) No current shortage Hepatitis A Virus / Inactivated (Havrix) No current shortage

Guides: what to do when your medication is in shortage · how to read shortage reports

Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.